MedPath

Efficacy of Saegmaeksangagambang on arterioslcerosis

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0002648
Lead Sponsor
Dongshin Korean Medilcine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Both men and women aged 19-75
2. Taking Saegmaeksangagambang
3. Who voluntarily participating in the study and voluntarily signed to the informed consent form

Exclusion Criteria

1. Who taking other herbal medicine during last 2 weeks
2. Who taking alcohol and caffeine on the day before the visit and on the day of visit
3. Who receive other traditional Korean medicine intervention such as acupuncture, pharmacoacupuncture , moxibustion or cupping therapy.
4. Who taking female hormone preparation during last month

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
second derivative phlethysmorgraphy(SDPTG)
Secondary Outcome Measures
NameTimeMethod
Heart Rate Variability(HRV);Augmentation Index(AI);Inbody;Total Cholesterol(TC), Triglyceride(TG), High Density Lipoprotein Cholesterol(HDL), Low Density Lipoprotein Chloesterol(LDL), Glucose, Aspartate Aminotransferase(AST), Alanine Aminotransferase(ALT), Alkaline phosphatase(ALP), Gamma-Glutamyl Transferase(GGT),Total Bilirubin(TB), Direct Bilirubin(DB), Albumin(ALB), Total Protein(TP);Measure yourself medical outcom profile(Mymop2);Pattern Identification questionnaire
© Copyright 2025. All Rights Reserved by MedPath